# Fatty Liver Study in Patients With Type II Diabetes

> **NCT02365233** · PHASE4 · TERMINATED · sponsor: **The University of Texas Medical Branch, Galveston** · enrollment: 5 (actual)

## Conditions studied

- Type II Diabetes
- Nonalcoholic Fatty Liver

## Interventions

- **DRUG:** DPP4 inhibitor
- **DRUG:** Pioglitazone
- **DRUG:** Lantus insulin

## Key facts

- **NCT ID:** NCT02365233
- **Lead sponsor:** The University of Texas Medical Branch, Galveston
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-05-01
- **Primary completion:** 2016-12-31
- **Final completion:** 2016-12-31
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** IRB withheld the data due to inadequate supporting documentation
- **Last updated:** 2018-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02365233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02365233, "Fatty Liver Study in Patients With Type II Diabetes". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02365233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*